The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 322.50
Ask: 323.50
Change: -4.50 (-1.38%)
Spread: 1.00 (0.31%)
Open: 326.50
High: 326.50
Low: 322.00
Prev. Close: 326.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

31 Mar 2020 07:00

RNS Number : 1265I
Morgan Advanced Materials PLC
31 March 2020
 

 

 

Press Release

Morgan Advanced Materials plc

31 March 2020

 

COVID-19 update

 

 

Our employees and customers

 

The health, safety and wellbeing of our employees is our absolute priority. We are following the varying advice of local governments around the world as the situation develops, and have wound down some operations and closed sites in geographies where that is required. We also continue operations with heightened safety measures where appropriate, and we continue to service customers in key industries such as healthcare, food production, energy and critical infrastructure.

 

Financial and operational performance

 

Sales for the 12 weeks to 21 March 2020 were 3.2% lower for the Group, on an organic constant-currency basis, compared to the same period of last year. Excluding China, the group was 0.2% lower than the prior year.

 

By business, the organic-constant currency trends for the same period compared to prior year are as follows. Within the Carbon & Technical Ceramics division, sales were 0.6% lower than the prior year, with growth in Seals & Bearings partially offsetting a decline in Electrical Carbon, and with Technical Ceramics broadly flat. Sales for the Thermal Products division were 6.7% lower than the prior year.

 

While we are currently seeing the position improve in China, with all of our factories there reopened, the COVID-19 outbreak has escalated globally. At this point we have six businesses closed across Italy, India and South Africa. The situation remains highly uncertain and it is therefore impossible to predict with any degree of certainty the impact this will have. We are consequently withdrawing our previous guidance for 2020.

 

Mitigating actions and financial position

 

While significant uncertainty exists around the impact of COVID-19, we have taken immediate action to reduce costs and improve cash flow and liquidity. These include reductions to capital expenditure other than for vital health, safety and environmental matters, a temporary hiring freeze for all but the most critical roles, and a curtailment of discretionary expenditure. The Board members have agreed to a 30% salary reduction, effective 1 April, for the rest of the financial year.

 

With respect to our financial position, we have no debt maturities until 2023, and as at 31 December 2019 we had:

 

· net debt excluding lease liabilities of £157 million

· a net debt / EBITDA ratio (pre-IFRS16) of 1.0 compared to a covenant not to exceed 3.0

· interest cover (pre-IFRS16) of 17.6 compared to a covenant to be greater than 4.0

· cash of £68 million and £150 million of headroom under our committed £200 million revolving credit facility.

 

Despite the strength of the Group's balance sheet, given the rising level of uncertainty as to how the situation will develop, we are taking all appropriate measures to preserve the Group's cash and liquidity position. Accordingly, the Board has decided to withdraw the proposed 2019 final dividend which was due to be approved at our forthcoming Annual General Meeting. The Board has also decided to suspend the dividend payable on the preference shares. We will review these dividend decisions later in the year once the outlook is clearer.

 

We have a global diversified business, a clear strategy and a strong balance sheet. We remain focussed on protecting our colleagues, containing our costs and preserving our financial position.

 

 

 

This announcement contains inside information. The person responsible for the release of this announcement on behalf of Morgan Advanced Materials plc is Peter Turner, Chief Financial Officer.

 

 

For further enquiries:

 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

 

Nina Coad

 

 

Brunswick

 

0207 404 5959 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFSDVDIIVII
Date   Source Headline
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding
10th May 20134:55 pmRNSResult of AGM
10th May 201310:00 amRNSAppointment of a Non-Executive Director
10th May 20137:00 amRNSInterim Management Statement
24th Apr 201312:09 pmRNSScrip Dividend Price
19th Apr 201311:20 amRNSDirector/PDMR Shareholding
10th Apr 201310:14 amRNSDirector/PDMR Shareholding
27th Mar 20135:38 pmRNSChange of Name
26th Mar 20134:25 pmRNSAnnual Financial Report
26th Mar 201311:44 amRNSDirector/PDMR Shareholding
14th Mar 20139:54 amRNSDirector/PDMR Shareholding
12th Mar 20131:50 pmRNSDirector/PDMR Shareholding
26th Feb 20133:55 pmRNSHolding(s) in Company
19th Feb 20131:09 pmRNSHolding(s) in Company
19th Feb 20131:08 pmRNSHolding(s) in Company
14th Feb 20137:05 amRNSChange of responsibilities of a director
14th Feb 20137:00 amRNSFull Year Results
5th Feb 20135:40 pmRNSHolding(s) in Company
31st Jan 201310:44 amRNSTotal Voting Rights
18th Jan 201312:38 pmRNSHolding(s) in Company
15th Jan 20132:07 pmRNSDirector/PDMR Shareholding
10th Jan 20139:54 amRNSTotal Voting Rights
3rd Jan 20133:47 pmRNSIssue of Equity
18th Dec 20124:54 pmRNSBlocklisting Interim Review
11th Dec 20129:35 amRNSDirector/PDMR Shareholding
6th Dec 20129:59 amRNSDirector/PDMR Shareholding
6th Dec 20129:55 amRNSDirector/PDMR Shareholding
29th Nov 20129:07 amRNSScrip Dividend Price
30th Oct 20125:08 pmRNSHolding(s) in Company
30th Oct 20129:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.